The Nasdaq Biotechnology Index fell 2.6% as Fulcrum Therapeutics shares and Abivax American Depositary Receipts (ADRs) plummeted following the release of trial results.
2026-06-02
The Nasdaq Biotechnology Index fell 2.6% as Fulcrum Therapeutics shares and Abivax American Depositary Receipts (ADRs) plummeted following the release of trial results.